메뉴 건너뛰기




Volumn 54, Issue 9, 2010, Pages 785-792

Metabolic disorders in emerging and neglected infectious diseases;Distúrbios metabólicos em doenças infecciosas emergentes e negligenciadas

Author keywords

Aids; Cardiovascular disease; Diabetes mellitus; Hepatitis; HIV; Infection; Leishmaniasis; Leprosy; Metabolic disorders; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMUNICABLE DISEASE; DEVELOPING COUNTRY; HUMAN; NEGLECTED DISEASE; POPULATION DYNAMICS; REVIEW; STATISTICS;

EID: 79951976388     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000900003     Document Type: Review
Times cited : (3)

References (60)
  • 1
    • 78650343402 scopus 로고    scopus 로고
    • Transição demográfica e epidemiológica
    • Medronho RA, Bloch KV, Luiz RR, Werneck GL., 2.ed. São Paulo: Atheneu
    • Pontes RJ, Ramos-Júnior AN, Kerr LRS, Bosi MLM. Transição demográfica e epidemiológica. In: Medronho RA, Bloch KV, Luiz RR, Werneck GL. Epidemiologia. 2.ed. São Paulo: Atheneu; 2009. p. 123-52.
    • (2009) Epidemiologia , pp. 123-152
    • Pontes, R.J.1    Ramos Jr., A.N.2    Kerr, L.R.S.3    Bosi, M.L.M.4
  • 2
    • 68049111240 scopus 로고    scopus 로고
    • Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana
    • Maia IL, Nicolau JC, Machado MN, Maia LN, Takakura IT, Rocha PRF, et al. Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana. Arq Bras Cardiol. 2009; 92(6): 439-45.
    • (2009) Arq Bras Cardiol , vol.92 , Issue.6 , pp. 439-445
    • Maia, I.L.1    Nicolau, J.C.2    Machado, M.N.3    Maia, L.N.4    Takakura, I.T.5    Rocha, P.R.F.6
  • 3
    • 0035134609 scopus 로고    scopus 로고
    • Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
    • Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001; 32(1):130-9.
    • (2001) Clin Infect Dis , vol.32 , Issue.1 , pp. 130-139
    • Hadigan, C.1    Meigs, J.B.2    Corcoran, C.3    Rietschel, P.4    Piecuch, S.5    Basgoz, N.6
  • 4
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121): 860-7.
    • (2006) Nature , vol.444 , Issue.7121 , pp. 860-867
    • Hotamisligil, G.S.1
  • 6
    • 76149105182 scopus 로고    scopus 로고
    • Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV
    • Kramer AS, Lazzarotto AR, Sprinz E, Manfroi WC. Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV. Arq Bras Cardiol. 2009; 93(5): 561-8.
    • (2009) Arq Bras Cardiol , vol.93 , Issue.5 , pp. 561-568
    • Kramer, A.S.1    Lazzarotto, A.R.2    Sprinz, E.3    Manfroi, W.C.4
  • 7
    • 19344373051 scopus 로고    scopus 로고
    • Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter Aids cohort study
    • Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter Aids cohort study. Arch Intern Med. 2005; 165(10): 1179-84.
    • (2005) Arch Intern Med , vol.165 , Issue.10 , pp. 1179-1184
    • Brown, T.T.1    Cole, S.R.2    Li, X.3    Kingsley, L.A.4    Palella, F.J.5    Riddler, S.A.6
  • 8
    • 28444483137 scopus 로고    scopus 로고
    • HIV infection and high-density lipoprotein: The effect of disease vs the effect of treatment
    • Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D. HIV infection and high-density lipoprotein: the effect of disease vs the effect of treatment. Metabolism. 2006; 55(1): 90-95.
    • (2006) Metabolism , vol.55 , Issue.1 , pp. 90-95
    • Rose, H.1    Woolley, I.2    Hoy, J.3    Dart, A.4    Bryant, B.5    Mijch, A.6    Sviridov, D.7
  • 9
    • 67651125105 scopus 로고    scopus 로고
    • Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
    • Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009; 23(9): 1059-67.
    • (2009) AIDS , vol.23 , Issue.9 , pp. 1059-1067
    • Hsue, P.Y.1    Hunt, P.W.2    Schnell, A.3    Kalapus, S.C.4    Hoh, R.5    Ganz, P.6
  • 10
    • 36348999732 scopus 로고    scopus 로고
    • HIV-associated dyslipidaemia: Pathogenesis and treatment
    • Oh J, Hegele RA. HIV-associated dyslipidaemia: pathogenesis and treatment. Lancet Infect Dis. 2007; 7(12): 787-96.
    • (2007) Lancet Infect Dis , vol.7 , Issue.12 , pp. 787-796
    • Oh, J.1    Hegele, R.A.2
  • 11
    • 0038030965 scopus 로고    scopus 로고
    • Human immunodeficiency virus/ highly active antiretroviral therapy-associated metabolic syndrome: Clinical presentation, pathophysiology, and therapeutic strategies
    • Leow MK, Addy CL, Mantzoros CS. Human immunodeficiency virus/ highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. J Clin Endocrinol Metab. 2003; 88(5): 1961-76.
    • (2003) J Clin Endocrinol Metab , vol.88 , Issue.5 , pp. 1961-1976
    • Leow, M.K.1    Addy, C.L.2    Mantzoros, C.S.3
  • 12
    • 38949121641 scopus 로고    scopus 로고
    • Short-term effect of HAART on blood pressure in HIV-infected individuals
    • Grandominico CJ, Fichtenbaum JM. Short-term effect of HAART on blood pressure in HIV-infected individuals. HIV Clin Trials. 2008; 9(1): 52-60.
    • (2008) HIV Clin Trials , vol.9 , Issue.1 , pp. 52-60
    • Grandominico, C.J.1    Fichtenbaum, J.M.2
  • 13
    • 49249121166 scopus 로고    scopus 로고
    • Approach to the human immunodeficiency virus- -infected patient with lipodystrophy
    • Brown TT. Approach to the human immunodeficiency virus- -infected patient with lipodystrophy. J Clin Endocrinol Metab. 2008; 93(8): 2937-45.
    • (2008) J Clin Endocrinol Metab , vol.93 , Issue.8 , pp. 2937-2945
    • Brown, T.T.1
  • 14
    • 11344293751 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(1): 48-62.
    • (2005) N Engl J Med , vol.352 , Issue.1 , pp. 48-62
    • Grinspoon, S.1    Carr, A.2
  • 16
    • 34247537169 scopus 로고    scopus 로고
    • Class of antiretroviral drugs and the risk of myocardial infarction
    • DAD Study Group
    • DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17): 1723-35.
    • (2007) N Engl J Med , vol.356 , Issue.17 , pp. 1723-1735
    • Friis-Møller, N.1    Reiss, P.2    Sabin, C.A.3    Weber, R.4    Monforte, A.5
  • 17
    • 44349148421 scopus 로고    scopus 로고
    • Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk
    • Tebas P, Henry WK, Matining R, Weng-Cherng D, Schmitz J, Valdez H, et al. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS One. 2008; 3(4): e2021.
    • (2008) PLoS One , vol.3 , Issue.4
    • Tebas, P.1    Henry, W.K.2    Matining, R.3    Weng-Cherng, D.4    Schmitz, J.5    Valdez, H.6
  • 19
    • 34248394654 scopus 로고    scopus 로고
    • Management of antiretroviral treatment- -related complications
    • Hoffman RM, Currier JS. Management of antiretroviral treatment- -related complications. Infect Dis Clin N Am. 2007; 21(1): 103-32.
    • (2007) Infect Dis Clin N Am , vol.21 , Issue.1 , pp. 103-132
    • Hoffman, R.M.1    Currier, J.S.2
  • 20
    • 67749111421 scopus 로고    scopus 로고
    • Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in c-reactive protein or fibrinogen
    • Lima LMA, Wiernsperger N, Kraemer-Aguiar LG, Bouskela E. Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in c-reactive protein or fibrinogen. Clinics. 2009; 64(5): 415-20.
    • (2009) Clinics , vol.64 , Issue.5 , pp. 415-420
    • Lima, L.M.A.1    Wiernsperger, N.2    Kraemer-Aguiar, L.G.3    Bouskela, E.4
  • 21
    • 67650572201 scopus 로고    scopus 로고
    • Use of drugs that act on the cytochrome p450 system in the elderly
    • Cabrera MAS, Dip RM, Furlan MO, Rodrigues SL. Use of drugs that act on the cytochrome p450 system in the elderly. Clinics. 2009; 64(4): 273-8.
    • (2009) Clinics , vol.64 , Issue.4 , pp. 273-278
    • Cabrera, M.A.S.1    Dip, R.M.2    Furlan, M.O.3    Rodrigues, S.L.4
  • 22
    • 33750227103 scopus 로고    scopus 로고
    • A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy
    • Moyle GJ, Sabin CA, Cartledge J, Johnson M, Wilkins E, Churchill D, et al. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. Aids. 2006; 20(16): 2043-50.
    • (2006) Aids , vol.20 , Issue.16 , pp. 2043-2050
    • Moyle, G.J.1    Sabin, C.A.2    Cartledge, J.3    Johnson, M.4    Wilkins, E.5    Churchill, D.6
  • 23
    • 25444514523 scopus 로고    scopus 로고
    • Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: A prospective study
    • Guaraldi G, Orlando G, De Fazio D, De Lorenzi I, Rottino A, De Santis G, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005; 10(6): 753-9.
    • (2005) Antivir Ther , vol.10 , Issue.6 , pp. 753-759
    • Guaraldi, G.1    Orlando, G.2    De Fazio, D.3    De Lorenzi, I.4    Rottino, A.5    De Santis, G.6
  • 24
    • 17244372383 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • Behrens GM. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(16): 1721-2.
    • (2005) N Engl J Med , vol.352 , Issue.16 , pp. 1721-1722
    • Behrens, G.M.1
  • 25
    • 77954699155 scopus 로고    scopus 로고
    • The role of testosterone in type 2 diabetes and metabolic syndrome in men
    • Saad F. The role of testosterone in type 2 diabetes and metabolic syndrome in men. Arq Bras Endocrinol Metab. 2009; 53(8): 901-7.
    • (2009) Arq Bras Endocrinol Metab , vol.53 , Issue.8 , pp. 901-907
    • Saad, F.1
  • 30
    • 77956468283 scopus 로고    scopus 로고
    • The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection
    • Mohamadkhani A, Sayemiri K, Ghanbari R, Elahi E, Poustchi H, Montazeri G. The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Virol J. 2010; 14(7): 228.
    • (2010) Virol J , vol.14 , Issue.7 , pp. 228
    • Mohamadkhani, A.1    Sayemiri, K.2    Ghanbari, R.3    Elahi, E.4    Poustchi, H.5    Montazeri, G.6
  • 31
    • 59449099132 scopus 로고    scopus 로고
    • Liver Int. Hepatitis C, insulin resistance and diabetes: Clinical and pathogenic data
    • Serfaty L, Capeau J. Liver Int. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009; 29(Suppl2): 13-25.
    • (2009) Liver Int , vol.29 , Issue.SUPPL. 2 , pp. 13-25
    • Serfaty, L.1    Capeau, J.2
  • 32
    • 33746366223 scopus 로고    scopus 로고
    • Proinflammatory, cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study
    • Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory, cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care. 2006; 29(5): 1096-101.
    • (2006) Diabetes Care , vol.29 , Issue.5 , pp. 1096-1101
    • Lecube, A.1    Hernandez, C.2    Genesca, J.3    Simo, R.4
  • 33
    • 38649120719 scopus 로고    scopus 로고
    • Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
    • Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008; 134(2): 416-23.
    • (2008) Gastroenterology , vol.134 , Issue.2 , pp. 416-423
    • Moucari, R.1    Asselah, T.2    Cazals-Hatem, D.3    Voitot, H.4    Boyer, N.5    Ripault, M.P.6
  • 34
    • 67549093932 scopus 로고    scopus 로고
    • Type B insulin resistance developing during interferon-alpha therapy
    • Daniel AL, Houlihan JL, Blum JS, Walsh JP. Type B insulin resistance developing during interferon-alpha therapy. Endocr Pract. 2009; 15(2): 153-7.
    • (2009) Endocr Pract , vol.15 , Issue.2 , pp. 153-157
    • Daniel, A.L.1    Houlihan, J.L.2    Blum, J.S.3    Walsh, J.P.4
  • 36
    • 33847629709 scopus 로고    scopus 로고
    • Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
    • Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007; 30(3): 734-43.
    • (2007) Diabetes Care , vol.30 , Issue.3 , pp. 734-743
    • Tolman, K.G.1    Fonseca, V.2    Dalpiaz, A.3    Tan, M.H.4
  • 37
    • 77952565412 scopus 로고    scopus 로고
    • Insulin resistance and response to antiviral therapy in chronic hepatitis C: Mechanisms and management
    • Del Campo JA, López RA, Romero-Gómez M. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management. Dig Dis. 2010; 28(1): 285-93.
    • (2010) Dig Dis , vol.28 , Issue.1 , pp. 285-293
    • del Campo, J.A.1    López, R.A.2    Romero-Gómez, M.3
  • 39
    • 77956262741 scopus 로고    scopus 로고
    • Virus infections and type 1 diabetes risk
    • Roivainen M, Klingel K. Virus infections and type 1 diabetes risk. Curr Diab Rep. 2010; 10(5): 350-6.
    • (2010) Curr Diab Rep , vol.10 , Issue.5 , pp. 350-356
    • Roivainen, M.1    Klingel, K.2
  • 40
    • 79951991522 scopus 로고    scopus 로고
    • Enteroviral pathogenesis of type 1 diabetes
    • Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discov Med. 2010; 10(51): 151-60.
    • (2010) Discov Med , vol.10 , Issue.51 , pp. 151-160
    • Hober, D.1    Sane, F.2
  • 41
    • 1542345055 scopus 로고    scopus 로고
    • Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells
    • Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004; 47(2): 225-39.
    • (2004) Diabetologia , vol.47 , Issue.2 , pp. 225-239
    • Ylipaasto, P.1    Klingel, K.2    Lindberg, A.M.3    Otonkoski, T.4    Kandolf, R.5    Hovi, T.6
  • 42
    • 67349224990 scopus 로고    scopus 로고
    • Infection and type 1 diabetes mellitus a two edged sword?
    • Goldberg E, Krause I. Infection and type 1 diabetes mellitus - a two edged sword? Autoimmun Rev. 2009; 8(8): 682-6.
    • (2009) Autoimmun Rev , vol.8 , Issue.8 , pp. 682-686
    • Goldberg, E.1    Krause, I.2
  • 44
    • 48749129542 scopus 로고    scopus 로고
    • Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies
    • Jeon C, Murray M. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7): e152.
    • (2008) PLoS Med , vol.5 , Issue.7
    • Jeon, C.1    Murray, M.2
  • 45
    • 1442275317 scopus 로고    scopus 로고
    • Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
    • Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004; 27(3): 813-23.
    • (2004) Diabetes Care , vol.27 , Issue.3 , pp. 813-823
    • Pickup, J.C.1
  • 46
    • 71549126811 scopus 로고    scopus 로고
    • Tuberculosis and diabetes mellitus: Convergence of two epidemics
    • Dooley K, Chaisson R. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9(12): 737-46.
    • (2009) Lancet Infect Dis , vol.9 , Issue.12 , pp. 737-746
    • Dooley, K.1    Chaisson, R.2
  • 47
    • 76649116564 scopus 로고    scopus 로고
    • Tuberculosis and AIDS co-morbidity in Brazil: Linkage of the tuberculosis and AIDS databases
    • Miranda AE, Golub JE, Lucena FF, Maciel EN, Gurgel MF, Dietze R. Tuberculosis and AIDS co-morbidity in Brazil: linkage of the tuberculosis and AIDS databases. Braz J Infect Dis. 2009; 13(2): 137-41.
    • (2009) Braz J Infect Dis , vol.13 , Issue.2 , pp. 137-141
    • Miranda, A.E.1    Golub, J.E.2    Lucena, F.F.3    Maciel, E.N.4    Gurgel, M.F.5    Dietze, R.6
  • 48
    • 0025793540 scopus 로고
    • The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans
    • Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin Pharmacokinet. 1991; 20(6): 477-90.
    • (1991) Clin Pharmacokinet , vol.20 , Issue.6 , pp. 477-490
    • Gwilt, P.R.1    Nahhas, R.R.2    Tracewell, W.G.3
  • 51
    • 0034979614 scopus 로고    scopus 로고
    • Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide
    • Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther. 2001; 69(6): 400-6.
    • (2001) Clin Pharmacol Ther , vol.69 , Issue.6 , pp. 400-406
    • Niemi, M.1    Backman, J.T.2    Neuvonen, M.3    Neuvonen, P.J.4    Kivisto, K.T.5
  • 52
    • 71549160447 scopus 로고
    • Increased insulin requirement in a patient with type 1 diabetes on rifampicin
    • Atkin S, Masson E, Bodmer C, Walker B, White M. Increased insulin requirement in a patient with type 1 diabetes on rifampicin. Diab Med. 1992; 10(4): 202.
    • (1992) Diab Med , vol.10 , Issue.4 , pp. 202
    • Atkin, S.1    Masson, E.2    Bodmer, C.3    Walker, B.4    White, M.5
  • 53
    • 79951974879 scopus 로고    scopus 로고
    • Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína (a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchowiana
    • Dalpino D, Magna LA, Opromolla DV. Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína (a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchowiana. Hansen Int. 1997; 22(2): 20-30.
    • (1997) Hansen Int , vol.22 , Issue.2 , pp. 20-30
    • Dalpino, D.1    Magna, L.A.2    Opromolla, D.V.3
  • 54
    • 77949355221 scopus 로고    scopus 로고
    • 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Immune therapies of type 1 diabetes: New opportunities based on the hygiene hypothesis
    • Chatenoud L, You S, Okada H, Kuhn C, Michaud B, Bach JF. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis. Clin Exp Immunol. 2010; 160(1): 106-12.
    • (2010) Clin Exp Immunol , vol.160 , Issue.1 , pp. 106-112
    • Chatenoud, L.1    You, S.2    Okada, H.3    Kuhn, C.4    Michaud, B.5    Bach, J.F.6
  • 55
    • 0014901004 scopus 로고
    • Schistosomiasis and diabetes mellitus
    • Bibawi E. Schistosomiasis and diabetes mellitus. Trans R Soc Trop Med Hyg. 1970; 64(6): 907-8.
    • (1970) Trans R Soc Trop Med Hyg , vol.64 , Issue.6 , pp. 907-908
    • Bibawi, E.1
  • 56
    • 0032923558 scopus 로고    scopus 로고
    • Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice
    • Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999; 21(4): 169-76.
    • (1999) Parasite Immunol , vol.21 , Issue.4 , pp. 169-176
    • Cooke, A.1    Tonks, P.2    Jones, F.M.3    O'Shea, H.4    Hutchings, P.5    Fulford, A.J.6
  • 57
    • 0031666963 scopus 로고    scopus 로고
    • An evaluation of the marmoset Callithrix jacchus (sagüi) as an experimental model for the dyslipoproteinemia of human Schistosomiasis mansoni
    • Lima VL, Sena VL, Stewart B, Owen JS, Dolphin PJ. An evaluation of the marmoset Callithrix jacchus (sagüi) as an experimental model for the dyslipoproteinemia of human Schistosomiasis mansoni. Biochim Biophys Acta. 1998; 1393(2-3): 235-43.
    • (1998) Biochim Biophys Acta , vol.1393 , Issue.2-3 , pp. 235-243
    • Lima, V.L.1    Sena, V.L.2    Stewart, B.3    Owen, J.S.4    Dolphin, P.J.5
  • 58
    • 0020472333 scopus 로고
    • Diabetes mellitus associated with pentamidine mesylate
    • Belehu A, Naafs B. Diabetes mellitus associated with pentamidine mesylate. Lancet. 1982; 1(8287): 1463-4.
    • (1982) Lancet , vol.1 , Issue.8287 , pp. 1463-1464
    • Belehu, A.1    Naafs, B.2
  • 60
    • 0036022344 scopus 로고    scopus 로고
    • Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis
    • Liberopoulos E, Alexandridis G, Bairaktari E, Elisaf M. Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis. Ann Clin Lab Sci. 2002; 32(3): 305-8.
    • (2002) Ann Clin Lab Sci , vol.32 , Issue.3 , pp. 305-308
    • Liberopoulos, E.1    Alexandridis, G.2    Bairaktari, E.3    Elisaf, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.